Genscript Biotech
ISIN KYG3825B1059
|WKN A2ACSB
Market cap (in EUR)
2,649.98 m
Country
China
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.
Healthcare Healthcare Services Miscellaneous Healthcare China
Financials
Key metrics
| Market capitalisation, EUR | 2,649.98 m |
| EPS, EUR | - |
| P/B ratio | 0.67 |
| P/E ratio | 0.90 |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 553.90 m |
| Net income, EUR | -62.11 m |
| Profit margin | -11.21% |
What ETF is Genscript Biotech in?
There are 83 ETFs which contain Genscript Biotech. All of these ETFs are listed in the table below. The ETF with the largest weighting of Genscript Biotech is the Global X Genomics & Biotechnology UCITS ETF.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
